Global Tumor Ablation Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Tumor Ablation Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
According to APO Research, The global Tumor Ablation market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Tumor Ablation include Angiodynamics, Medtronic, Boston Scientific, Misonix, Sonacare Medical, EDAP TMS, Chongqing Haifu Medical, HealthTronics and J &J, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Ablation.
The Tumor Ablation market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
Tumor Ablation segment by Type

Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Tumor Ablation segment by Application

Liver Cancer
Lung Cancer
Kidney Cancer
Others
Tumor Ablation Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Tumor Ablation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Tumor Ablation Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Tumor Ablation Sales Estimates and Forecasts (2019-2030)
1.3 Tumor Ablation Market by Type
1.3.1 Radiofrequency (RF) Ablation
1.3.2 Microwave Ablation
1.3.3 Cryoablation
1.3.4 Other Technologies
1.4 Global Tumor Ablation Market Size by Type
1.4.1 Global Tumor Ablation Market Size Overview by Type (2019-2030)
1.4.2 Global Tumor Ablation Historic Market Size Review by Type (2019-2024)
1.4.3 Global Tumor Ablation Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Tumor Ablation Sales Breakdown by Type (2019-2024)
1.5.2 Europe Tumor Ablation Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Tumor Ablation Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Tumor Ablation Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Tumor Ablation Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Tumor Ablation Industry Trends
2.2 Tumor Ablation Industry Drivers
2.3 Tumor Ablation Industry Opportunities and Challenges
2.4 Tumor Ablation Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Tumor Ablation Revenue (2019-2024)
3.2 Global Top Players by Tumor Ablation Sales (2019-2024)
3.3 Global Top Players by Tumor Ablation Price (2019-2024)
3.4 Global Tumor Ablation Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Tumor Ablation Key Company Manufacturing Sites & Headquarters
3.6 Global Tumor Ablation Company, Product Type & Application
3.7 Global Tumor Ablation Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Tumor Ablation Market CR5 and HHI
3.8.2 Global Top 5 and 10 Tumor Ablation Players Market Share by Revenue in 2023
3.8.3 2023 Tumor Ablation Tier 1, Tier 2, and Tier 3
4 Tumor Ablation Regional Status and Outlook
4.1 Global Tumor Ablation Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Tumor Ablation Historic Market Size by Region
4.2.1 Global Tumor Ablation Sales in Volume by Region (2019-2024)
4.2.2 Global Tumor Ablation Sales in Value by Region (2019-2024)
4.2.3 Global Tumor Ablation Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Tumor Ablation Forecasted Market Size by Region
4.3.1 Global Tumor Ablation Sales in Volume by Region (2025-2030)
4.3.2 Global Tumor Ablation Sales in Value by Region (2025-2030)
4.3.3 Global Tumor Ablation Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Tumor Ablation by Application
5.1 Tumor Ablation Market by Application
5.1.1 Liver Cancer
5.1.2 Lung Cancer
5.1.3 Kidney Cancer
5.1.4 Others
5.2 Global Tumor Ablation Market Size by Application
5.2.1 Global Tumor Ablation Market Size Overview by Application (2019-2030)
5.2.2 Global Tumor Ablation Historic Market Size Review by Application (2019-2024)
5.2.3 Global Tumor Ablation Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Tumor Ablation Sales Breakdown by Application (2019-2024)
5.3.2 Europe Tumor Ablation Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Tumor Ablation Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Tumor Ablation Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Tumor Ablation Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Angiodynamics
6.1.1 Angiodynamics Comapny Information
6.1.2 Angiodynamics Business Overview
6.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angiodynamics Tumor Ablation Product Portfolio
6.1.5 Angiodynamics Recent Developments
6.2 Medtronic
6.2.1 Medtronic Comapny Information
6.2.2 Medtronic Business Overview
6.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Tumor Ablation Product Portfolio
6.2.5 Medtronic Recent Developments
6.3 Boston Scientific
6.3.1 Boston Scientific Comapny Information
6.3.2 Boston Scientific Business Overview
6.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Tumor Ablation Product Portfolio
6.3.5 Boston Scientific Recent Developments
6.4 Misonix
6.4.1 Misonix Comapny Information
6.4.2 Misonix Business Overview
6.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Misonix Tumor Ablation Product Portfolio
6.4.5 Misonix Recent Developments
6.5 Sonacare Medical
6.5.1 Sonacare Medical Comapny Information
6.5.2 Sonacare Medical Business Overview
6.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sonacare Medical Tumor Ablation Product Portfolio
6.5.5 Sonacare Medical Recent Developments
6.6 EDAP TMS
6.6.1 EDAP TMS Comapny Information
6.6.2 EDAP TMS Business Overview
6.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 EDAP TMS Tumor Ablation Product Portfolio
6.6.5 EDAP TMS Recent Developments
6.7 Chongqing Haifu Medical
6.7.1 Chongqing Haifu Medical Comapny Information
6.7.2 Chongqing Haifu Medical Business Overview
6.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
6.7.5 Chongqing Haifu Medical Recent Developments
6.8 HealthTronics
6.8.1 HealthTronics Comapny Information
6.8.2 HealthTronics Business Overview
6.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HealthTronics Tumor Ablation Product Portfolio
6.8.5 HealthTronics Recent Developments
6.9 J &J
6.9.1 J &J Comapny Information
6.9.2 J &J Business Overview
6.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 J &J Tumor Ablation Product Portfolio
6.9.5 J &J Recent Developments
7 North America by Country
7.1 North America Tumor Ablation Sales by Country
7.1.1 North America Tumor Ablation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Tumor Ablation Sales by Country (2019-2024)
7.1.3 North America Tumor Ablation Sales Forecast by Country (2025-2030)
7.2 North America Tumor Ablation Market Size by Country
7.2.1 North America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Tumor Ablation Market Size by Country (2019-2024)
7.2.3 North America Tumor Ablation Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Tumor Ablation Sales by Country
8.1.1 Europe Tumor Ablation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Tumor Ablation Sales by Country (2019-2024)
8.1.3 Europe Tumor Ablation Sales Forecast by Country (2025-2030)
8.2 Europe Tumor Ablation Market Size by Country
8.2.1 Europe Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Tumor Ablation Market Size by Country (2019-2024)
8.2.3 Europe Tumor Ablation Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Tumor Ablation Sales by Country
9.1.1 Asia-Pacific Tumor Ablation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Tumor Ablation Sales by Country (2019-2024)
9.1.3 Asia-Pacific Tumor Ablation Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Tumor Ablation Market Size by Country
9.2.1 Asia-Pacific Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Tumor Ablation Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Tumor Ablation Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Tumor Ablation Sales by Country
10.1.1 Latin America Tumor Ablation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Tumor Ablation Sales by Country (2019-2024)
10.1.3 Latin America Tumor Ablation Sales Forecast by Country (2025-2030)
10.2 Latin America Tumor Ablation Market Size by Country
10.2.1 Latin America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Tumor Ablation Market Size by Country (2019-2024)
10.2.3 Latin America Tumor Ablation Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Tumor Ablation Sales by Country
11.1.1 Middle East and Africa Tumor Ablation Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Tumor Ablation Sales by Country (2019-2024)
11.1.3 Middle East and Africa Tumor Ablation Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Tumor Ablation Market Size by Country
11.2.1 Middle East and Africa Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Tumor Ablation Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Tumor Ablation Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Tumor Ablation Value Chain Analysis
12.1.1 Tumor Ablation Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Tumor Ablation Production Mode & Process
12.2 Tumor Ablation Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Tumor Ablation Distributors
12.2.3 Tumor Ablation Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings